Summary

HNY Research projects that the Hematology Controls market size will grow from 373.8 Million USD in 2025 to 591.44 Million USD by 2031, at an estimated CAGR of 7.95%. The base year considered for the study is 2025, and the market size is projected from 2026 to 2031.This report presents a detailed and holistic analysis of the global Hematology Controls market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Hematology Controls manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.

By Market Players:
Sysmex
Danaher
Bio-Rad
Mindray
Abbott
Horiba
Boule
Diatron

By Type
3-Part Hematology Controls
5-Part Hematology Controls
Others

By Application
Hospital
Independent Lab
Others

By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hematology Controls Revenue
1.4 Market Analysis by Type
1.4.1 Global Hematology Controls Market Size Growth Rate by Type: 2026-2031
1.4.2 3-Part Hematology Controls
1.4.3 5-Part Hematology Controls
1.4.4 Others
1.5 Market by Application
1.5.1 Global Hematology Controls Market Share by Application: 2026-2031
1.5.2 Hospital
1.5.3 Independent Lab
1.5.4 Others
1.6 Study Objectives
1.7 Overview of Global Hematology Controls Market
1.7.1 Global Hematology Controls Market Status and Outlook (2020-2031)
1.7.2 North America
1.7.3 East Asia
1.7.4 Europe
1.7.5 South Asia
1.7.6 Southeast Asia
1.7.7 Middle East
1.7.8 Africa
1.7.9 Oceania
1.7.10 South America
1.7.11 Rest of the World
2 Manufacturing Cost Structure Analysis
2.1 Manufacturing Cost Structure Analysis of Hematology Controls
2.2 Industry Chain Structure of Hematology Controls
3 Market Competition by Manufacturers
3.1 Global Hematology Controls Production Capacity Market Share by Manufacturers (2020-2025)
3.2 Global Hematology Controls Revenue Market Share by Manufacturers (2020-2025)
3.3 Global Hematology Controls Average Price by Manufacturers (2020-2025)
4 Hematology Controls Regional Market Analysis
4.1 Hematology Controls Production by Regions
4.1.1 Global Hematology Controls Production by Regions (2020-2025)
4.1.2 Global Hematology Controls Revenue by Regions
4.2 Hematology Controls Consumption by Regions
4.3 North America Hematology Controls Market Analysis
4.3.1 North America Hematology Controls Production
4.3.2 North America Hematology Controls Revenue
4.3.3 Key Manufacturers in North America
4.3.4 North America Hematology Controls Import and Export
4.4 East Asia Hematology Controls Market Analysis
4.4.1 East Asia Hematology Controls Production
4.4.2 East Asia Hematology Controls Revenue
4.4.3 Key Manufacturers in East Asia
4.4.4 East Asia Hematology Controls Import & Export
4.5 Europe Hematology Controls Market Analysis
4.5.1 Europe Hematology Controls Production
4.5.2 Europe Hematology Controls Revenue
4.5.3 Key Manufacturers in Europe
4.5.4 Europe Hematology Controls Import & Export
4.6 South Asia Hematology Controls Market Analysis
4.6.1 South Asia Hematology Controls Production
4.6.2 South Asia Hematology Controls Revenue
4.6.3 Key Manufacturers in South Asia
4.6.4 South Asia Hematology Controls Import & Export
4.7 Southeast Asia Hematology Controls Market Analysis
4.7.1 Southeast Asia Hematology Controls Production
4.7.2 Southeast Asia Hematology Controls Revenue
4.7.3 Key Manufacturers in Southeast Asia
4.7.4 Southeast Asia Hematology Controls Import & Export
4.8 Middle East Hematology Controls Market Analysis
4.8.1 Middle East Hematology Controls Production
4.8.2 Middle East Hematology Controls Revenue
4.8.3 Key Manufacturers in Middle East
4.8.4 Middle East Hematology Controls Import & Export
4.9 Africa Hematology Controls Market Analysis
4.9.1 Africa Hematology Controls Production
4.9.2 Africa Hematology Controls Revenue
4.9.3 Key Manufacturers in Africa
4.9.4 Africa Hematology Controls Import & Export
4.10 Oceania Hematology Controls Market Analysis
4.10.1 Oceania Hematology Controls Production
4.10.2 Oceania Hematology Controls Revenue
4.10.3 Key Manufacturers in Oceania
4.10.4 Oceania Hematology Controls Import & Export
4.11 South America Hematology Controls Market Analysis
4.11.1 South America Hematology Controls Production
4.11.2 South America Hematology Controls Revenue
4.11.3 Key Manufacturers in South America
4.11.4 South America Hematology Controls Import & Export
5 Hematology Controls Sales Market by Type (2020-2031)
5.1 Global Hematology Controls Historic Market Size by Type (2020-2025)
5.2 Global Hematology Controls Forecasted Market Size by Type (2026-2031)
6 Hematology Controls Consumption Market by Application(2020-2031)
6.1 Global Hematology Controls Historic Market Size by Application (2020-2025)
6.2 Global Hematology Controls Forecasted Market Size by Application (2026-2031)
7 Company Profiles and Key Figures in Hematology Controls Business
7.1 Sysmex
7.1.1 Sysmex Company Profile
7.1.2 Sysmex Hematology Controls Product Specification
7.1.3 Sysmex Hematology Controls Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.2 Danaher
7.2.1 Danaher Company Profile
7.2.2 Danaher Hematology Controls Product Specification
7.2.3 Danaher Hematology Controls Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.3 Bio-Rad
7.3.1 Bio-Rad Company Profile
7.3.2 Bio-Rad Hematology Controls Product Specification
7.3.3 Bio-Rad Hematology Controls Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.4 Mindray
7.4.1 Mindray Company Profile
7.4.2 Mindray Hematology Controls Product Specification
7.4.3 Mindray Hematology Controls Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.5 Abbott
7.5.1 Abbott Company Profile
7.5.2 Abbott Hematology Controls Product Specification
7.5.3 Abbott Hematology Controls Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.6 Horiba
7.6.1 Horiba Company Profile
7.6.2 Horiba Hematology Controls Product Specification
7.6.3 Horiba Hematology Controls Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.7 Boule
7.7.1 Boule Company Profile
7.7.2 Boule Hematology Controls Product Specification
7.7.3 Boule Hematology Controls Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.8 Diatron
7.8.1 Diatron Company Profile
7.8.2 Diatron Hematology Controls Product Specification
7.8.3 Diatron Hematology Controls Production Capacity, Revenue, Price and Gross Margin (2020-2025)
8 Production and Supply Forecast
8.1 Global Forecasted Production of Hematology Controls (2026-2031)
8.2 Global Forecasted Revenue of Hematology Controls (2026-2031)
8.3 Global Forecasted Price of Hematology Controls (2020-2031)
8.4 Global Forecasted Production of Hematology Controls by Region (2026-2031)
8.4.1 North America Hematology Controls Production, Revenue Forecast (2026-2031)
8.4.2 East Asia Hematology Controls Production, Revenue Forecast (2026-2031)
8.4.3 Europe Hematology Controls Production, Revenue Forecast (2026-2031)
8.4.4 South Asia Hematology Controls Production, Revenue Forecast (2026-2031)
8.4.5 Southeast Asia Hematology Controls Production, Revenue Forecast (2026-2031)
8.4.6 Middle East Hematology Controls Production, Revenue Forecast (2026-2031)
8.4.7 Africa Hematology Controls Production, Revenue Forecast (2026-2031)
8.4.8 Oceania Hematology Controls Production, Revenue Forecast (2026-2031)
8.4.9 South America Hematology Controls Production, Revenue Forecast (2026-2031)
8.4.10 Rest of the World Hematology Controls Production, Revenue Forecast (2026-2031)
8.5 Forecast by Type and by Application (2026-2031)
8.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2026-2031)
8.5.2 Global Forecasted Consumption of Hematology Controls by Application (2026-2031)
9 Consumption and Demand Forecast
9.1 North America Forecasted Consumption of Hematology Controls by Country
9.2 East Asia Market Forecasted Consumption of Hematology Controls by Country
9.3 Europe Market Forecasted Consumption of Hematology Controls by Countriy
9.4 South Asia Forecasted Consumption of Hematology Controls by Country
9.5 Southeast Asia Forecasted Consumption of Hematology Controls by Country
9.6 Middle East Forecasted Consumption of Hematology Controls by Country
9.7 Africa Forecasted Consumption of Hematology Controls by Country
9.8 Oceania Forecasted Consumption of Hematology Controls by Country
9.9 South America Forecasted Consumption of Hematology Controls by Country
9.10 Rest of the world Forecasted Consumption of Hematology Controls by Country
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer